"“We will continue to respond to the regulatory reviews regarding safety signals related to dulaglutide as part of our routine regulatory review processes.”Subscribe to Well Adjusted, our newsletter full of simple strategies to work smarter and live better, from the Fortune Well team."

Read this story from "Fortune" for free without being tracked.

https://read.distractionfree.site/fortune/2023/12/01/suicide-risk-weight-loss-drugs-ozempic-glp-1/

#suicide #loss #EuropeanUnion’s #PharmaCompanies #EliLilly #Ozempic #EuropeanMedicines